W.G. Bill Hefner VA Medical Center

Salisbury, North Carolina 28144

1 studies enrolling now · 14 studies all time

What they study most

Carcinoma, Non-Squamous Non-Small Cell Lung, Castration Resistant Prostatic Cancer, Immune Thrombocytopenic Purpura, Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Obesity, Pre-diabetes, Prostate Cancer, Prostate Cancer Metastatic, Refractory Cancer

Studies at this site

• Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer — Recruiting now
• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening — Running, not enrolling
• Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer — Stopped early
• Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) — Completed
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer — Completed
• Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study — Completed
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
• Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy — NO_LONGER_AVAILABLE